Kiarri N Kershaw1, Tené T Lewis2, Ana V Diez Roux3, Nancy S Jenny4, Kiang Liu1, Frank J Penedo5, Mercedes R Carnethon1. 1. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine. 2. Department of Epidemiology, Rollins School of Public Health, Emory University. 3. Department of Epidemiology and Biostatistics, Drexel University School of Public Health. 4. Department of Pathology, University of Vermont College of Medicine. 5. Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine.
Abstract
OBJECTIVE: To examine associations of lifetime and everyday discrimination with inflammation independent of sociodemographic characteristics. METHOD: Cross-sectional associations of self-reported experiences of everyday discrimination and lifetime discrimination with interleukin-6 (IL-6) and C-reactive protein (CRP) were examined by gender in a multiethnic sample of 3,099 men and 3,468 women aged 45-84 years. Everyday discrimination, lifetime discrimination due to any attribution, and lifetime discrimination attributed to race/ethnicity were based on self-report, and IL-6 and CRP were assayed from blood samples. RESULTS: Among women, higher levels of all 3 discrimination measures were significantly associated with higher IL-6 in models adjusted for sociodemographic characteristics, recent infection, anti-inflammatory medication use, and hormone replacement therapy use. All associations were attenuated with adjustment for body mass index (BMI). For men, everyday discrimination was inversely associated with IL-6 in all adjusted models. Lifetime discrimination was not related to IL-6 among men. Discrimination was unassociated with CRP in all models for both men and women. CONCLUSIONS: The association between discrimination and inflammation varied by gender and marker of inflammation. These findings highlight the complex relationship between discrimination and cardiovascular disease (CVD) risk and point to areas in need of further research. (PsycINFO Database Record (c) 2016 APA, all rights reserved).
OBJECTIVE: To examine associations of lifetime and everyday discrimination with inflammation independent of sociodemographic characteristics. METHOD: Cross-sectional associations of self-reported experiences of everyday discrimination and lifetime discrimination with interleukin-6 (IL-6) and C-reactive protein (CRP) were examined by gender in a multiethnic sample of 3,099 men and 3,468 women aged 45-84 years. Everyday discrimination, lifetime discrimination due to any attribution, and lifetime discrimination attributed to race/ethnicity were based on self-report, and IL-6 and CRP were assayed from blood samples. RESULTS: Among women, higher levels of all 3 discrimination measures were significantly associated with higher IL-6 in models adjusted for sociodemographic characteristics, recent infection, anti-inflammatory medication use, and hormone replacement therapy use. All associations were attenuated with adjustment for body mass index (BMI). For men, everyday discrimination was inversely associated with IL-6 in all adjusted models. Lifetime discrimination was not related to IL-6 among men. Discrimination was unassociated with CRP in all models for both men and women. CONCLUSIONS: The association between discrimination and inflammation varied by gender and marker of inflammation. These findings highlight the complex relationship between discrimination and cardiovascular disease (CVD) risk and point to areas in need of further research. (PsycINFO Database Record (c) 2016 APA, all rights reserved).
Authors: Mahasin S Mujahid; Ana V Diez Roux; Richard C Cooper; Steven Shea; David R Williams Journal: Am J Hypertens Date: 2010-09-16 Impact factor: 2.689
Authors: Kiarri N Kershaw; Briana Mezuk; Cleopatra M Abdou; Jane A Rafferty; James S Jackson Journal: Health Psychol Date: 2010-05 Impact factor: 4.267
Authors: Amani M Allen; Yijie Wang; David H Chae; Melisa M Price; Wizdom Powell; Teneka C Steed; Angela Rose Black; Firdaus S Dhabhar; Leticia Marquez-Magaña; Cheryl L Woods-Giscombe Journal: Ann N Y Acad Sci Date: 2019-08-12 Impact factor: 5.691
Authors: Boback Ziaeian; Gerald F Kominski; Michael K Ong; Vickie M Mays; Robert H Brook; Gregg C Fonarow Journal: Circ Cardiovasc Qual Outcomes Date: 2017-07
Authors: Miriam E Van Dyke; Viola Vaccarino; Sandra B Dunbar; Priscilla Pemu; Gary H Gibbons; Arshed A Quyyumi; Tené T Lewis Journal: Psychoneuroendocrinology Date: 2017-04-23 Impact factor: 4.905
Authors: Amani M Allen; Marilyn D Thomas; Eli K Michaels; Alexis N Reeves; Uche Okoye; Melisa M Price; Rebecca E Hasson; S Leonard Syme; David H Chae Journal: Psychoneuroendocrinology Date: 2018-09-05 Impact factor: 4.905
Authors: Karen L Saban; Herbert L Mathews; Fred B Bryant; Dina Tell; Cara Joyce; Holli A DeVon; Linda Witek Janusek Journal: Brain Behav Immun Date: 2018-07-17 Impact factor: 7.217